{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/LIXT/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-09-29T04:53:09.218Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":11507,"canonical_name":"LIXTE BIOTECHNOLOGY HOLDINGS, INC.","cik":"0001335105","uei":null,"lei":null,"duns":null,"ticker":"LIXT"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":24},"count":24,"timeline":[{"ts":"2026-07-17","kind":"sec.filing","form_type":"PRE 14A","title":"PRE 14A — NOMAD POWER SOLUTIONS, INC. — 2026-07-17","url_slug":"/sec/cik-0001335105/pre-14a/0001493152-26-033809","accession_number":"0001493152-26-033809","importance":30},{"ts":"2026-07-02","kind":"sec.filing","form_type":"8-K","title":"8-K — LIXTE BIOTECHNOLOGY HOLDINGS, INC. — 2026-07-02","url_slug":"/sec/cik-0001335105/8-k/0001493152-26-031870","accession_number":"0001493152-26-031870","importance":35},{"ts":"2026-07-02","kind":"sec.filing","form_type":"3","title":"3 — LIXTE BIOTECHNOLOGY HOLDINGS, INC. — 2026-07-02","url_slug":"/sec/cik-0001335105/3/0001493152-26-031723","accession_number":"0001493152-26-031723","importance":30},{"ts":"2026-07-02","kind":"sec.filing","form_type":"4","title":"4 — LIXTE BIOTECHNOLOGY HOLDINGS, INC. — 2026-07-02","url_slug":"/sec/cik-0001335105/4/0001493152-26-031882","accession_number":"0001493152-26-031882","importance":30},{"ts":"2026-07-02","kind":"sec.filing","form_type":"4","title":"4 — LIXTE BIOTECHNOLOGY HOLDINGS, INC. — 2026-07-02","url_slug":"/sec/cik-0001335105/4/0001493152-26-031885","accession_number":"0001493152-26-031885","importance":30},{"ts":"2026-07-02","kind":"sec.filing","form_type":"4","title":"4 — LIXTE BIOTECHNOLOGY HOLDINGS, INC. — 2026-07-02","url_slug":"/sec/cik-0001335105/4/0001493152-26-031888","accession_number":"0001493152-26-031888","importance":30},{"ts":"2026-07-02","kind":"sec.filing","form_type":"4","title":"4 — LIXTE BIOTECHNOLOGY HOLDINGS, INC. — 2026-07-02","url_slug":"/sec/cik-0001335105/4/0001493152-26-031890","accession_number":"0001493152-26-031890","importance":30},{"ts":"2026-07-02","kind":"sec.filing","form_type":"4","title":"4 — LIXTE BIOTECHNOLOGY HOLDINGS, INC. — 2026-07-02","url_slug":"/sec/cik-0001335105/4/0001493152-26-031893","accession_number":"0001493152-26-031893","importance":30},{"ts":"2026-07-02","kind":"sec.filing","form_type":"4","title":"4 — LIXTE BIOTECHNOLOGY HOLDINGS, INC. — 2026-07-02","url_slug":"/sec/cik-0001335105/4/0001493152-26-031896","accession_number":"0001493152-26-031896","importance":30},{"ts":"2026-07-01","kind":"sec.insider.a","reporter":"Felix Lourdes","title":"","shares":30000,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-01","kind":"sec.insider.a","reporter":"Holloway Michael Andrew","title":"","shares":15000,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-01","kind":"sec.insider.a","reporter":"Primus Guy Warren","title":"","shares":15000,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-01","kind":"sec.insider.a","reporter":"Pursglove Geordan Garrett","title":"CEO and Chairman of the Board","shares":350000,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-01","kind":"sec.insider.a","reporter":"Sawyer Jason David","title":"","shares":40000,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-01","kind":"sec.insider.a","reporter":"Stazzone Peter","title":"Chief Financial Officer","shares":50000,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-18","kind":"sec.filing","form_type":"8-K","title":"8-K — LIXTE BIOTECHNOLOGY HOLDINGS, INC. — 2026-06-18","url_slug":"/sec/cik-0001335105/8-k/0001493152-26-029308","accession_number":"0001493152-26-029308","importance":35},{"ts":"2026-06-16","kind":"sec.filing","form_type":"8-K","title":"8-K — LIXTE BIOTECHNOLOGY HOLDINGS, INC. — 2026-06-16","url_slug":"/sec/cik-0001335105/8-k/0001493152-26-028878","accession_number":"0001493152-26-028878","importance":35},{"ts":"2026-06-09","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — LIXTE BIOTECHNOLOGY HOLDINGS, INC. — 2026-06-09","url_slug":"/sec/cik-0001335105/schedule-13g/0001213900-26-066986","accession_number":"0001213900-26-066986","importance":55},{"ts":"2026-06-04","kind":"sec.filing","form_type":"8-K","title":"8-K — LIXTE BIOTECHNOLOGY HOLDINGS, INC. — 2026-06-04","url_slug":"/sec/cik-0001335105/8-k/0001493152-26-027307","accession_number":"0001493152-26-027307","importance":35},{"ts":"2026-06-04","kind":"sec.filing","form_type":"424B5","title":"424B5 — LIXTE BIOTECHNOLOGY HOLDINGS, INC. — 2026-06-04","url_slug":"/sec/cik-0001335105/424b5/0001493152-26-027286","accession_number":"0001493152-26-027286","importance":30},{"ts":"2026-06-01","kind":"sec.filing","form_type":"8-K","title":"8-K — LIXTE BIOTECHNOLOGY HOLDINGS, INC. — 2026-06-01","url_slug":"/sec/cik-0001335105/8-k/0001493152-26-026544","accession_number":"0001493152-26-026544","importance":35},{"ts":"2026-06-01","kind":"sec.filing","form_type":"3","title":"3 — LIXTE BIOTECHNOLOGY HOLDINGS, INC. — 2026-06-01","url_slug":"/sec/cik-0001335105/3/0001493152-26-026607","accession_number":"0001493152-26-026607","importance":30},{"ts":"2026-06-01","kind":"sec.filing","form_type":"4","title":"4 — LIXTE BIOTECHNOLOGY HOLDINGS, INC. — 2026-06-01","url_slug":"/sec/cik-0001335105/4/0001493152-26-026608","accession_number":"0001493152-26-026608","importance":30},{"ts":"2026-05-29","kind":"sec.insider.a","reporter":"Porter Stuart D","title":"","shares":25000,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15}]}